title: Modelling the early detection of breast cancer.
abstract: A mathematical model was developed to predict the outcome of early detection clinical trials or programs targeted at evaluating mortality benefit from earlier diagnosis of breast cancer. The model was applied to eight randomized breast cancer trials, which were carried out to evaluate the benefits of mammography, physical examination or their combination. The model assumes that breast cancer is a progressive disease and any mortality benefit from earlier diagnosis is generated from a favorable shift in the stage at diagnosis relative to usual care. The model predicted the reduction in mortality for seven of the eight trials within the reported confidence intervals. Input data required by the models are: stage shift distribution, examination schedules, population age distribution, follow up time, and survival conditional on stage at diagnosis. Survival distributions were obtained from the 1973-82 SEER database whereas the remaining data was obtained for each of the trials. Information on sensitivity and stage was ordinarily available during the early phase of the trials. The theoretical model has the promise of being able to predict the long-term outcome of early detection trials or programs during the initial examination phase. The theoretical model is general and may be applied to other chronic diseases, which satisfy the basic assumptions.
authors.affiliation: Dana-Farber Cancer Institute and the Harvard School of Public Health, Boston, MA 02115, USA. sjlee@jimmy.harvard.edu
authors.forename: S J
authors.initials: SJ
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Zelen
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality*; D016504:Breast Self-Examination / Q000379:methods*; D005260:Female; D006801:Humans; D008327:Mammography / Q000379:methods*; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D008962:Models, Theoretical; D009367:Neoplasm Staging; D015995:Prevalence; D011336:Probability; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D018426:SEER Program; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D013997:Time Factors